Examination of the bone marrow can be used to evaluate the prognosis in patients with primary myelodysplasia. This can be done independent of clinical and other laboratory data. This score was developed at the Medizinische Hochschule in Hannover, Germany.

To read more or access our algorithms and calculators, please log in or register.